NEW YORK (GenomeWeb news) – GenoLogics said today that Pfizer will license its lab and data management software under a three-year, global agreement.
Victoria, British Columbia-based GenoLogics said Pfizer will use its software suite to “capture, contextualize and integrate science data in multiple locations worldwide.”
The GenoLogics integrated software products are used for “managing biorepositories and clinical annotations to lab and data management systems for genomics, proteomics and other sciences,” the company said.
Pfizer’s Head of BBC Informatics, Giles Day, said that the GenoLogics software “can be customized at the lab level, including instrument integrations and data imports, while allowing us to analyze data across sciences and labs.”
Financial terms of the agreement were not released.